Clinical Trial Update: Effect and Safety Study of Atorvastatin to Treat Chronic Subdural Hematoma [Phase 2]

View source ↗

Summary

Phase 2 trial assessing the effectiveness and safety of atorvastatin for chronic subdural hematoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Subdural Hematoma

Drugs mentioned

• atorvastatin (atorvastatin)

Snippet

Sponsor: Oriental Neurosurgery Evidence-Based-Study Team | Conditions: Chronic Subdural Hematoma | Phase 2 | Status: COMPLETED